11:15:09 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-13 Kvartalsrapport 2024-Q3
2024-08-21 Kvartalsrapport 2024-Q2
2024-05-15 Kvartalsrapport 2024-Q1
2024-03-28 Ordinarie utdelning CESSA 0.00 DKK
2024-03-27 Årsstämma 2024
2024-02-29 Bokslutskommuniké 2023
2023-11-16 Kvartalsrapport 2023-Q3
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-12 Kvartalsrapport 2023-Q1
2023-03-24 Ordinarie utdelning CESSA 0.00 DKK
2023-03-23 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-11-18 Kvartalsrapport 2022-Q3
2022-11-04 Extra Bolagsstämma 2022
2022-08-19 Kvartalsrapport 2022-Q2
2022-04-19 Kvartalsrapport 2022-Q1
2022-03-18 Ordinarie utdelning CESSA 0.00 DKK
2022-03-17 Årsstämma 2022
2022-02-24 Bokslutskommuniké 2021
2021-11-19 Kvartalsrapport 2021-Q3
2021-08-19 Kvartalsrapport 2021-Q2
2021-04-19 Kvartalsrapport 2021-Q1
2021-03-29 Ordinarie utdelning CESSA 0.00 DKK
2021-03-26 Årsstämma 2021
2021-02-11 Bokslutskommuniké 2020

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriBioteknik
Cessatech är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom forskning och utveckling av smärtstillande nässpray som vidare används för behandling av akuta smärttillstånd hos barn. Utöver huvudverksamheten erbjuds även tillhörande kringtjänster och relaterade produkter. Verksamheten drivs globalt med störst närvaro inom den nordiska marknaden. Huvudkontoret ligger i Köpenhamn.
2021-12-14 08:00:00

Copenhagen, Denmark, 14 December 2021 - Tuesday, 14 December 2021, is the last day of trading in warrants of series TO 1 on Spotlight Stock Market. The warrants of series TO 1 were issued in connection with Cessatech A/S ("Cessatech" or the "Company") IPO of units that took place in November/December 2020. Each (1) warrant of series TO 1 entitles the holder to subscribe for one (1) new share in Cessatech. Last day to exercise the warrants of series TO 1 and subscribe for shares is 16 December 2021. Note that the banks/nominees need to be notified well in advance before the exercise period ends

Each (1) warrant of series TO 1 entitles the holder to subscribe for one (1) new share in Cessatech at a price of DKK 10.00 per share. Warrants of series TO 1 that have not been exercised by Thursday 16 December 2021 or sold by Tuesday 14 December 2021 will expire and therefore be worthless. Holders of warrants of series TO 1 need to take action and instruct their respective bank/nominee in due time before the last day in the exercise period. Note that the banks/nominees need to be notified well in advance before the exercise period ends.

Teaser and subscription form
Teaser and subscription forms are available on the websites of Cessatech (www.cessatech.com (https://cessatech.com/investor/filings-reports/)), Sedermera Fondkommission (www.sedermera.se) and Nordic Issuing (www.nordic-issuing.se).

For further information regarding the exercise of warrants, please contact:
Sedermera Fondkommission
Phone: +46 40 - 615 14 10
E-mail: info@sedermera.se
www.sedermera.se

Nordic Issuing
Phone: +46 (0)40-632 00 20
E-mail: info@nordic-issuing.se
www.nordic-issuing.se